Cargando…
WIP1 phosphatase as pharmacological target in cancer therapy
DNA damage response (DDR) pathway protects cells from genome instability and prevents cancer development. Tumor suppressor p53 is a key molecule that interconnects DDR, cell cycle checkpoints, and cell fate decisions in the presence of genotoxic stress. Inactivating mutations in TP53 and other genes...
Autores principales: | Pecháčková, Soňa, Burdová, Kamila, Macurek, Libor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442293/ https://www.ncbi.nlm.nih.gov/pubmed/28439615 http://dx.doi.org/10.1007/s00109-017-1536-2 |
Ejemplares similares
-
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3
por: Pechackova, Sona, et al.
Publicado: (2016) -
WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors
por: Burdova, Kamila, et al.
Publicado: (2019) -
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1
checkpoint
por: Kleiblova, Petra, et al.
Publicado: (2013) -
DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase
por: Brazina, Jan, et al.
Publicado: (2015) -
WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
por: Richter, Mark, et al.
Publicado: (2015)